Drug Profile
Ipratropium bromide dry-powder inhalation - ML Laboratories
Alternative Names: Ipratropium bromide Clickhaler; SCH 1000 dry-powder inhalation - ML LaboratoriesLatest Information Update: 24 Oct 2021
Price :
$50
*
At a glance
- Originator ML Laboratories
- Class Antiasthmatics; Antibronchitics; Atropine derivatives; Bronchodilators; Small molecules
- Mechanism of Action Muscarinic receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Asthma; Chronic obstructive pulmonary disease
Most Recent Events
- 17 Dec 2003 No development reported - Preclinical for Asthma in United Kingdom (Inhalation)
- 17 Dec 2003 No development reported - Preclinical for Chronic obstructive pulmonary disease in United Kingdom (Inhalation)
- 07 Jul 2000 Preclinical development for Asthma in United Kingdom (Inhalation)